Actinium to Participate in the Canaccord Genuity Rare Disease and Biopharma One-on-One Day on February 3rd Jan 28, 2015
Actinium Submits CMC Meeting Request to FDA for Iomab-B to Support IND Filing and Anticipated Commencement of Phase 3 Trial in Mid-2015 Jan 20, 2015
